A behavior-based drug screening system using a Caenorhabditis elegans model of motor neuron disease
Open Access
- 12 July 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-10
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive loss of motor neurons, for which there is no effective treatment. Previously, we generated a Caenorhabditis elegans model of ALS, in which the expression of dnc-1, the homologous gene of human dynactin-1, is knocked down (KD) specifically in motor neurons. This dnc-1 KD model showed progressive motor defects together with axonal and neuronal degeneration, as observed in ALS patients. In the present study, we established a behavior-based, automated, and quantitative drug screening system using this dnc-1 KD model together with Multi-Worm Tracker (MWT), and tested whether 38 candidate neuroprotective compounds could improve the mobility of the dnc-1 KD animals. We found that 12 compounds, including riluzole, which is an approved medication for ALS patients, ameliorated the phenotype of the dnc-1 KD animals. Nifedipine, a calcium channel blocker, most robustly ameliorated the motor deficits as well as axonal degeneration of dnc-1 KD animals. Nifedipine also ameliorated the motor defects of other motor neuronal degeneration models of C. elegans, including dnc-1 mutants and human TAR DNA-binding protein of 43 kDa overexpressing worms. Our results indicate that dnc-1 KD in C. elegans is a useful model for the screening of drugs against motor neuron degeneration, and that MWT is a powerful tool for the behavior-based screening of drugs.Keywords
This publication has 23 references indexed in Scilit:
- dnc-1/dynactin 1 Knockdown Disrupts Transport of Autophagosomes and Induces Motor Neuron DegenerationPLOS ONE, 2013
- Keeping track of worm trackersWormBook, 2012
- High-throughput behavioral analysis in C. elegansNature Methods, 2011
- A Survey of New Temperature-Sensitive, Embryonic-Lethal Mutations in C. elegans: 24 Alleles of Thirteen GenesPLOS ONE, 2011
- Neurotoxic effects of TDP-43 overexpression in C. elegansHuman Molecular Genetics, 2010
- DCTN1 mutations in Perry syndromeNature Genetics, 2009
- The Parallel Worm Tracker: A Platform for Measuring Average Speed and Drug-Induced Paralysis in NematodesPLOS ONE, 2008
- Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosisAnnals of Neurology, 2005
- Mutant dynactin in motor neuron diseaseNature Genetics, 2003
- Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformationProceedings of the National Academy of Sciences, 2000